AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.
Silica Bioreplicated Cellular Platforms as Adjuvants and Vaccines
Technology Benefits
Allows for development of versatiletumor vaccinesRetains innate structural featuresand take on additional properties, such as enhanced stability duringdehydrationEase of distribution and transport –vaccines remain effective through extreme temperatures and pressuresLong-term vaccine/adjuvant storagewithout loss of immunogenic propertiesTransformation of cancer cells intoimmunogenic pathogen mimicsDecreased cost in vaccine production
Detailed Technology Description
A novel process to transform cells into stable,potent vaccines and adjuvants.
Country/Region
USA
For more information, please click Here
